Skip to content

ARSEUS LAB

Active
Public limited companyfounded 199333 yrs activeMannebeekstraat 33, 8790 Waregem, BelgiumKBO/BCE: BE 0450.810.171
Summary

ARSEUS LAB has been active since 1993 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €3.1m and a net result of €228,254. Equity is growing by ~5% per year across the filed fiscal years. Its solvency ranks better than 59% of 6131 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.3% (very low).

Checked score

Score 2024
Axes · tick = 2023
Profitability49▲+3
Solvency76▲+8
Growth71=
Track record100
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €200,000 at 30 days acceptable
Liquidity short (current ratio 0.85 against 0.82 in 2023; short-term debt: 46.5% and cash: 4.3% of total assets), and 49.1% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 33 years 0 40 y
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Wholesale trade (NACE 46)
about 21% more bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
50.9%
Return on assets
3.7%
Age of the figures
21 mo
neutral · Latest accounts filed on time
The financial year that closed on 28-12-2024 was due by 28-07-2025 and was filed on 22-07-2025, 6 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2024
6 d early
2023
177 d late
2022
40 d early
2021
38 d early
2020
31 d early
2019
33 d early
2018
32 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average on the deadline day; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

ARSEUS LAB was incorporated on 3 September 1993.1 Revenue grew from EUR 6.8 million in 2018 to EUR 10 million in 2024 and headcount from 14.7 to 20.7 full-time equivalents.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2024

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2024, full schema

Turnover
€10.2m▲ 3.6%
2023 · €9.9m
EBIT margin
3.4%▲ 0.6pp
2023 · 2.8%
Net result
€228,254▲ 51.6%
2023 · €150,565
Working capital
-€441,837▲ 32.4%
2023 · -€653,516
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20202021202220232024
Turnover€6.3m▼ 10.0%€8.9m▲ 40.3%€10.0m▲ 12.8%€9.9m▼ 1.5%€10.2m▲ 3.6%
Operating result-€105,829▲ 4.4%€258,828€337,329▲ 30.3%€274,690▼ 18.6%€342,914▲ 24.8%
Net result-€120,702below the sector's middle half▲ 40.4%€162,698within the sector's middle half€252,211within the sector's middle half▲ 55.0%€150,565within the sector's middle half▼ 40.3%€228,254within the sector's middle half▲ 51.6%
EBIT margin-1.7%▼ 0.1pp2.9%▲ 4.6pp3.4%▲ 0.5pp2.8%▼ 0.6pp3.4%▲ 0.6pp
Equity€2.3mwithin the sector's middle half▼ 4.9%€2.5mwithin the sector's middle half▲ 6.9%€2.8mwithin the sector's middle half▲ 10.1%€2.9mwithin the sector's middle half▲ 5.5%€3.1mwithin the sector's middle half▲ 7.9%
Total assets€5.4mwithin the sector's middle half▼ 4.7%€5.7mwithin the sector's middle half▲ 5.8%€6.4mwithin the sector's middle half▲ 11.5%€6.8mwithin the sector's middle half▲ 6.5%€6.2mwithin the sector's middle half▼ 9.5%
Debt€3.1m▼ 4.5%€3.2m▲ 5.0%€3.6m▲ 12.6%€3.9m▲ 7.3%€3.0m▼ 22.5%
Working capital-€1.3mbelow the sector's middle half▼ 7.7%-€1.2mbelow the sector's middle half▲ 8.7%-€878,336below the sector's middle half▲ 27.3%-€653,516below the sector's middle half▲ 25.6%-€441,837below the sector's middle half▲ 32.4%
Solvency43.2%within the sector's middle half▼ 0.1pp43.7%within the sector's middle half▲ 0.5pp43.1%within the sector's middle half▼ 0.6pp42.7%within the sector's middle half▼ 0.4pp50.9%within the sector's middle half▲ 8.2pp
Current ratio0.56below the sector's middle half▼ 0.050.62below the sector's middle half▲ 0.060.75below the sector's middle half▲ 0.130.82below the sector's middle half▲ 0.070.85below the sector's middle half▲ 0.02
Return on assets (ROA)-2.2%below the sector's middle half▲ 1.3pp2.8%within the sector's middle half▲ 5.1pp3.9%within the sector's middle half▲ 1.1pp2.2%within the sector's middle half▼ 1.7pp3.7%within the sector's middle half▲ 1.5pp
Staff (FTE)16.5within the sector's middle half▼ 1.2%15.5within the sector's middle half▼ 6.1%16within the sector's middle half▲ 3.2%20within the sector's middle half▲ 25.0%20.7within the sector's middle half▲ 3.5%
above within below the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
-€200,000€0€200,000€400,000Operating result 2020: -€105,829-€105,829Net result 2020: -€120,702-€120,702Operating result 2021: €258,828€258,828Net result 2021: €162,698€162,698Operating result 2022: €337,329€337,329Net result 2022: €252,211€252,211Operating result 2023: €274,690€274,690Net result 2023: €150,565€150,565Operating result 2024: €342,914€342,914Net result 2024: €228,254€228,25420202021202220232024€0€100,000€200,000€300,000Operating result 2022: €337,329€337,000Net result 2022: €252,211€252,000Operating result 2023: €274,690€275,000Net result 2023: €150,565€151,000Operating result 2024: €342,914€343,000Net result 2024: €228,254€228,000202220232024
The operating result recovers in 2024; 2024 is 25% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €6.2m
Fixed assets €3.7m =
Current assets €2.4m ▼ 21.1%
Equity and liabilities €6.2m
Equity €3.1m ▲ 7.9%
Debt €3.0m ▼ 22.5%
Debt's share of the balance-sheet total falls from 57.3% to 49.1%. Equity is higher and debt is lower.
Key figures and ratios
2024 value · change against 2023
EBITDA
€367,197▲
2023 · €301,889
Cash flow
€252,537▲
2023 · €177,764
Quick ratio
0.83▲
2023 · 0.79
Debt to equity
0.97▼
2023 · 1.34
ROE
7.3%▲
2023 · 5.2%
Interest coverage
3.97▲
2023 · 3.73
Debt ≤ 1 year
€2.9m▼
2023 · €3.7m
Income taxes
€1,086▼
2023 · €1,791
Staff costs
€1.7m▲
2023 · €1.7m
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2024 against 2023 · 72 lines
Balance sheet Code20232024
Assets
Total assets20/58€6.8m€6.2m▼
Fixed assets21/28€3.7m€3.7m=
Intangible fixed assets21€43,191€66,493▲
Tangible fixed assets22/27€30,398€6,057▼
Plant, machinery and equipment23€23,894-
Furniture and vehicles24€6,503€6,057▼
Financial fixed assets28€3.7m€3.7m=
Affiliated companies280/1€3.7m€3.7m=
Participating interests280€3.7m€3.7m=
Other financial fixed assets284/8€475€475=
Amounts receivable and cash guarantees285/8€475€475=
Current assets29/58€3.1m€2.4m▼
Stocks and contracts in progress3€121,878€50,988▼
Stocks30/36€121,878€50,988▼
Goods purchased for resale34€121,878€50,988▼
Amounts receivable within one year40/41€2.7m€2.1m▼
Trade receivables40€2.7m€2.1m▼
Other amounts receivable41€3,716€11,610▲
Cash at bank and in hand54/58€215,965€262,061▲
Deferred charges and accrued income490/1€11,475€4,985▼
Equity and liabilities
Total equity and liabilities10/49€6.8m€6.2m▼
Equity10/15€2.9m€3.1m▲
Contributions10/11€5.5m€5.5m=
Capital10€5.5m€5.5m=
Issued capital100€20.5m€20.5m=
Uncalled capital101€15.0m€15.0m=
Reserves13€9,296€9,296=
Non-distributable reserves130/1€9,296€9,296=
Legal reserve130€9,296€9,296=
Profit (loss) carried forward14-€2.6m-€2.4m▲
Amounts payable17/49€3.9m€3.0m▼
Amounts payable within one year42/48€3.7m€2.9m▼
Financial debts43€2.0m€1.0m▼
Credit institutions430/8€2.0m€1.0m▼
Trade debts44€1.1m€1.4m▲
Suppliers440/4€1.1m€1.4m▲
Taxes, remuneration and social security45€568,438€435,635▼
Taxes450/3€301,619€204,765▼
Remuneration and social security454/9€266,819€230,871▼
Other amounts payable47/48-€1,094
Accrued charges and deferred income492/3€181,272€163,658▼
Income statement Code20232024
Operating income70/76A€11.2m€11.8m▲
Turnover70€9.9m€10.2m▲
Other operating income74€1.3m€1.6m▲
Non-recurring operating income76A€0€0=
Operating charges60/66A€10.9m€11.4m▲
Goods for resale, raw materials and consumables60€7.1m€7.5m▲
Purchases600/8€7.1m€7.2m▲
Change in stocks: decrease (increase)609-€47,332€338,377▲
Services and other goods61€1.6m€1.8m▲
Remuneration, social security and pensions62€1.7m€1.7m▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€27,199€24,283▼
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€65,679-€254,529▼
Other operating charges640/8€425,884€616,556▲
Operating profit (loss)9901€274,690€342,914▲
Financial income75/76B€1,681€12,817▲
Recurring financial income75€1,681€1,690▲
Income from current assets751€743€1,604▲
Other financial income752/9€939€86▼
Non-recurring financial income76B-€11,127
Financial charges65/66B€124,016€126,391▲
Recurring financial charges65€124,016€126,391▲
Debt charges650€81,025€92,591▲
Other financial charges652/9€42,991€33,800▼
Profit (loss) for the period before taxes9903€152,355€229,340▲
Income taxes67/77€1,791€1,086▼
Taxes670/3€1,791€1,086▼
Profit (loss) for the period9904€150,565€228,254▲
Profit (loss) for the period to be appropriated9905€150,565€228,254▲
Appropriation of the result
Profit (loss) to be appropriated9906-€2.6m-€2.4m▲
Profit (loss) brought forward from the previous period14P-€2.7m-€2.6m▲
Social balance
Average headcount (FTE)908720.020.7▲

The notes to these accounts (61 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20202021202220232024Change
Operating income70/76A-€10.3m€11.3m€11.2m€11.8m▲ 5.4%
Turnover70€6.3m€8.9m€10.0m€9.9m€10.2m▲ 3.6%
Other operating income74-€1.4m€1.3m€1.3m€1.6m▲ 19.1%
Non-recurring operating income76A-€32,042€0€0€0-
Operating charges60/66A-€10.0m€10.9m€10.9m€11.4m▲ 4.9%
Goods for resale, raw materials and consumables60-€6.5m€7.5m€7.1m€7.5m▲ 6.4%
Purchases600/8-€6.5m€7.4m€7.1m€7.2m▲ 0.9%
Change in stocks: decrease (increase)609-€48,717€100,703-€47,332€338,377▲ 815%
Services and other goods61-€1.6m€1.7m€1.6m€1.8m▲ 9.6%
Remuneration, social security and pensions62-€1.3m€1.3m€1.7m€1.7m▲ 3.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€25,362€28,104€31,620€27,199€24,283▼ 10.7%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4--€34,638-€50,647€65,679-€254,529▼ 488%
Other operating charges640/8-€573,751€529,818€425,884€616,556▲ 44.8%
Operating profit (loss)9901-€105,829€258,828€337,329€274,690€342,914▲ 24.8%
Financial income75/76B-€156€389€1,681€12,817▲ 662%
Recurring financial income75€3,263€156€389€1,681€1,690▲ 0.5%
Income from current assets751-€105€24€743€1,604▲ 116%
Other financial income752/9-€51€365€939€86▼ 90.8%
Non-recurring financial income76B----€11,127-
Financial charges65/66B-€93,114€83,152€124,016€126,391▲ 1.9%
Recurring financial charges65€75,372€93,114€83,152€124,016€126,391▲ 1.9%
Debt charges650€47,212€39,125€39,490€81,025€92,591▲ 14.3%
Other financial charges652/9-€53,989€43,662€42,991€33,800▼ 21.4%
Profit (loss) for the period before taxes9903-€118,778€165,870€254,565€152,355€229,340▲ 50.5%
Income taxes67/77€1,924€3,172€2,354€1,791€1,086▼ 39.4%
Taxes670/3-€3,172€2,354€1,791€1,086▼ 39.4%
Profit (loss) for the period9904-€120,702€162,698€252,211€150,565€228,254▲ 51.6%
Profit (loss) for the period to be appropriated9905-€120,702€162,698€252,211€150,565€228,254▲ 51.6%
Line20202021202220232024Change
Assets
Total assets20/58€5.4m€5.7m€6.4m€6.8m€6.2m▼ 9.5%
Fixed assets21/28€3.7m€3.8m€3.7m€3.7m€3.7m=
Intangible fixed assets21€32,134€48,898€41,096€43,191€66,493▲ 54.0%
Tangible fixed assets22/27€19,186€49,493€39,182€30,398€6,057▼ 80.1%
Plant, machinery and equipment23-€35,614€29,590€23,894--
Furniture and vehicles24-€13,879€9,592€6,503€6,057▼ 6.9%
Financial fixed assets28€3.7m€3.7m€3.7m€3.7m€3.7m=
Affiliated companies280/1-€3.7m€3.7m€3.7m€3.7m=
Participating interests280-€3.7m€3.7m€3.7m€3.7m=
Other financial fixed assets284/8-€822€822€475€475=
Amounts receivable and cash guarantees285/8-€822€822€475€475=
Current assets29/58€1.7m€2.0m€2.6m€3.1m€2.4m▼ 21.1%
Stocks and contracts in progress3€245,381€180,088€126,260€121,878€50,988▼ 58.2%
Stocks30/36-€180,088€126,260€121,878€50,988▼ 58.2%
Goods purchased for resale34-€180,088€126,260€121,878€50,988▼ 58.2%
Amounts receivable within one year40/41€1.4m€1.7m€2.3m€2.7m€2.1m▼ 22.7%
Trade receivables40-€1.7m€2.3m€2.7m€2.1m▼ 23.0%
Other amounts receivable41-€1,652€2,032€3,716€11,610▲ 212%
Cash at bank and in hand54/58€58,260€71,565€261,089€215,965€262,061▲ 21.3%
Deferred charges and accrued income490/1-€8,801€5,703€11,475€4,985▼ 56.6%
Equity and liabilities
Total equity and liabilities10/49€5.4m€5.7m€6.4m€6.8m€6.2m▼ 9.5%
Equity10/15€2.3m€2.5m€2.8m€2.9m€3.1m▲ 7.9%
Contributions10/11€5.5m€5.5m€5.5m€5.5m€5.5m=
Capital10-€5.5m€5.5m€5.5m€5.5m=
Issued capital100-€20.5m€20.5m€20.5m€20.5m=
Uncalled capital101-€15.0m€15.0m€15.0m€15.0m=
Reserves13€9,296€9,296€9,296€9,296€9,296=
Non-distributable reserves130/1-€9,296€9,296€9,296€9,296=
Legal reserve130-€9,296€9,296€9,296€9,296=
Profit (loss) carried forward14-€3.2m-€3.0m-€2.7m-€2.6m-€2.4m▲ 8.8%
Amounts payable17/49€3.1m€3.2m€3.6m€3.9m€3.0m▼ 22.5%
Amounts payable within one year42/48€3.0m€3.2m€3.5m€3.7m€2.9m▼ 23.1%
Financial debts43-€1.7m€1.5m€2.0m€1.0m▼ 50.5%
Credit institutions430/8-€1.7m€1.5m€2.0m€1.0m▼ 50.5%
Trade debts44€640,645€1.1m€1.6m€1.1m€1.4m▲ 27.0%
Suppliers440/4-€1.1m€1.6m€1.1m€1.4m▲ 27.0%
Advances received on contracts in progress46-€125,511----
Taxes, remuneration and social security45-€267,878€416,827€568,438€435,635▼ 23.4%
Taxes450/3-€128,679€262,677€301,619€204,765▼ 32.1%
Remuneration and social security454/9-€139,198€154,150€266,819€230,871▼ 13.5%
Other amounts payable47/48-€6,118€2,260-€1,094-
Accrued charges and deferred income492/3-€54,558€114,052€181,272€163,658▼ 9.7%
Line20202021202220232024Change
Profit (loss) for the period9904-€120,702€162,698€252,211€150,565€228,254▲ 51.6%
+ Depreciation and write-downs630€25,362€28,104€31,620€27,199€24,283▼ 10.7%
Operating cash flow (approximation)-€95,340€190,801€283,831€177,764€252,537▲ 42.1%
Investment in fixed assets (approximation)--€75,174-€13,506-€20,163-€23,244▼ 15.3%
Change in cash-€13,305€189,523-€45,124€46,096▲ 202%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2025
22-07
NBB filing Annual accounts filed
fiscal year 2024 · full schema
23-01
NBB filing Annual accounts filed
fiscal year 2023 · full schema · 177 days late
2023
21-06
NBB filing Annual accounts filed
fiscal year 2022 · full schema
2022
31-12
Financial Highest result since 2018net €252,211 ▲55%
Net result €252,211, the highest in the series.
17-06
NBB filing Annual accounts filed
fiscal year 2021 · full schema
2021
25-12
Financial Back to profitnet €162,698
Net result €162,698 after 3 loss-making years.
25-06
NBB filing Annual accounts filed
fiscal year 2020 · full schema
2020
25-06
NBB filing Annual accounts filed
fiscal year 2019 · full schema
2019
27-06
NBB filing Annual accounts filed
fiscal year 2018 · full schema
2018
21-06
NBB filing Annual accounts filed
fiscal year 2017 · full schema
2017
11-07
NBB filing Annual accounts filed
fiscal year 2016 · full schema
2016
08-07
NBB filing Annual accounts filed
fiscal year 2015 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 30 acts read
About the unread acts

We know of 30 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
30 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Waregem · 1 establishment unit since 1993
seat establishment The establishment unit on the map
Ground area
4,722 m²
Building footprint
2,553 m²
Volume, LiDAR
29,776 m³
Parcel 34453F0799/00K000, Flanders · tallest building 17.7 m, ±3 floors. Linked by address, not a title deed.
7 companies at this address See who is registered here
1 establishment unit
ARSEUS LAB
Mannebeekstraat 33, 8790 WaregemWholesale of pharmaceutical and medical goods
since 19932.063.678.463
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
34453F0799/00K000 Flanders 4,722 m² 1 · 2,553 m² 17.7 m · 3 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Owners and holdings

1 holding

Owners 0

The accounts to 28-12-2024 list no shareholders, and no other source names one.

Holdings 1

According to the annual accounts to 28-12-2024 of ARSEUS LAB and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

No current directors or connected companies found in the register.

Recognitions · licences · registrations

Legal Entity Identifier

5493003T6GZ9H1JBZ897
live in the LEI register

Similar companies · same sector, comparable size

Of 1,903 companies in sector 46460 we hold annual accounts for 1,126. 652 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPublic limited company
Founded03-09-1993
Fiscal year end28-12
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
E-invoicing
Reachable via Peppol
Peppol ID 0208:0450810171
Also 9925:BE0450810171
Registered 10-10-2023

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 29 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.